Precursors of high-grade serous carcinoma

Patricia A. Shaw, Blaise Clarke, Sophia George

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Knowledge of the molecular/genetic alterations and of the natural history of the cancer precursors that precede high-grade serous carcinoma continues to evolve. Comprehensive examination of the fallopian tubes removed from women at high genetic risk of ovarian cancer, usually carriers of germline mutations of BRCA1 or BRCA2, led to the discovery of serous cancer precursors in the distal end of the fallopian tube. Controversy about the cell of origin of high-grade serous carcinoma still exists. The presence of serous intraepithelial carcinoma (STIC) in the fallopian tube in the absence of invasive disease and the coexistence of STIC with high-grade serous carcinoma in sporadic as well as in hereditary HGSC strongly support the tubal epithelium as cell of origin. The consistent and reproducible diagnosis of STIC and related lesions depends on both careful processing of the fallopian tube following a SEE-FIM-like protocol and the application of a diagnostic algorithm incorporating morphology and immunohistochemistry. STIC and HGSC share common molecular and genetic alterations. Other lesions considered to be latent cancer precursors, the p53 signature and secretory cell outgrowth (SCOUT), have been described.

Original languageEnglish (US)
Title of host publicationPrecancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology
PublisherSpringer International Publishing
Pages3-22
Number of pages20
ISBN (Print)9783319225098, 9783319225081
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Fallopian Tubes
Carcinoma in Situ
Carcinoma
Molecular Biology
Neoplasms
Germ-Line Mutation
Ovarian Neoplasms
Epithelium
Immunohistochemistry

Keywords

  • Cell of origin
  • High-grade serous carcinoma
  • Ovarian cancer
  • P53 signature
  • Precursor lesions
  • Serous tubal intraepithelial carcinoma
  • Serous tubal intraepithelial lesion
  • Tumorigenesis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Shaw, P. A., Clarke, B., & George, S. (2015). Precursors of high-grade serous carcinoma. In Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology (pp. 3-22). Springer International Publishing. https://doi.org/10.1007/978-3-319-22509-8_1

Precursors of high-grade serous carcinoma. / Shaw, Patricia A.; Clarke, Blaise; George, Sophia.

Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology. Springer International Publishing, 2015. p. 3-22.

Research output: Chapter in Book/Report/Conference proceedingChapter

Shaw, PA, Clarke, B & George, S 2015, Precursors of high-grade serous carcinoma. in Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology. Springer International Publishing, pp. 3-22. https://doi.org/10.1007/978-3-319-22509-8_1
Shaw PA, Clarke B, George S. Precursors of high-grade serous carcinoma. In Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology. Springer International Publishing. 2015. p. 3-22 https://doi.org/10.1007/978-3-319-22509-8_1
Shaw, Patricia A. ; Clarke, Blaise ; George, Sophia. / Precursors of high-grade serous carcinoma. Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology. Springer International Publishing, 2015. pp. 3-22
@inbook{f5867c85502a491aa7e7622fa7047b84,
title = "Precursors of high-grade serous carcinoma",
abstract = "Knowledge of the molecular/genetic alterations and of the natural history of the cancer precursors that precede high-grade serous carcinoma continues to evolve. Comprehensive examination of the fallopian tubes removed from women at high genetic risk of ovarian cancer, usually carriers of germline mutations of BRCA1 or BRCA2, led to the discovery of serous cancer precursors in the distal end of the fallopian tube. Controversy about the cell of origin of high-grade serous carcinoma still exists. The presence of serous intraepithelial carcinoma (STIC) in the fallopian tube in the absence of invasive disease and the coexistence of STIC with high-grade serous carcinoma in sporadic as well as in hereditary HGSC strongly support the tubal epithelium as cell of origin. The consistent and reproducible diagnosis of STIC and related lesions depends on both careful processing of the fallopian tube following a SEE-FIM-like protocol and the application of a diagnostic algorithm incorporating morphology and immunohistochemistry. STIC and HGSC share common molecular and genetic alterations. Other lesions considered to be latent cancer precursors, the p53 signature and secretory cell outgrowth (SCOUT), have been described.",
keywords = "Cell of origin, High-grade serous carcinoma, Ovarian cancer, P53 signature, Precursor lesions, Serous tubal intraepithelial carcinoma, Serous tubal intraepithelial lesion, Tumorigenesis",
author = "Shaw, {Patricia A.} and Blaise Clarke and Sophia George",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-22509-8_1",
language = "English (US)",
isbn = "9783319225098",
pages = "3--22",
booktitle = "Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Precursors of high-grade serous carcinoma

AU - Shaw, Patricia A.

AU - Clarke, Blaise

AU - George, Sophia

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Knowledge of the molecular/genetic alterations and of the natural history of the cancer precursors that precede high-grade serous carcinoma continues to evolve. Comprehensive examination of the fallopian tubes removed from women at high genetic risk of ovarian cancer, usually carriers of germline mutations of BRCA1 or BRCA2, led to the discovery of serous cancer precursors in the distal end of the fallopian tube. Controversy about the cell of origin of high-grade serous carcinoma still exists. The presence of serous intraepithelial carcinoma (STIC) in the fallopian tube in the absence of invasive disease and the coexistence of STIC with high-grade serous carcinoma in sporadic as well as in hereditary HGSC strongly support the tubal epithelium as cell of origin. The consistent and reproducible diagnosis of STIC and related lesions depends on both careful processing of the fallopian tube following a SEE-FIM-like protocol and the application of a diagnostic algorithm incorporating morphology and immunohistochemistry. STIC and HGSC share common molecular and genetic alterations. Other lesions considered to be latent cancer precursors, the p53 signature and secretory cell outgrowth (SCOUT), have been described.

AB - Knowledge of the molecular/genetic alterations and of the natural history of the cancer precursors that precede high-grade serous carcinoma continues to evolve. Comprehensive examination of the fallopian tubes removed from women at high genetic risk of ovarian cancer, usually carriers of germline mutations of BRCA1 or BRCA2, led to the discovery of serous cancer precursors in the distal end of the fallopian tube. Controversy about the cell of origin of high-grade serous carcinoma still exists. The presence of serous intraepithelial carcinoma (STIC) in the fallopian tube in the absence of invasive disease and the coexistence of STIC with high-grade serous carcinoma in sporadic as well as in hereditary HGSC strongly support the tubal epithelium as cell of origin. The consistent and reproducible diagnosis of STIC and related lesions depends on both careful processing of the fallopian tube following a SEE-FIM-like protocol and the application of a diagnostic algorithm incorporating morphology and immunohistochemistry. STIC and HGSC share common molecular and genetic alterations. Other lesions considered to be latent cancer precursors, the p53 signature and secretory cell outgrowth (SCOUT), have been described.

KW - Cell of origin

KW - High-grade serous carcinoma

KW - Ovarian cancer

KW - P53 signature

KW - Precursor lesions

KW - Serous tubal intraepithelial carcinoma

KW - Serous tubal intraepithelial lesion

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84956818125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956818125&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-22509-8_1

DO - 10.1007/978-3-319-22509-8_1

M3 - Chapter

AN - SCOPUS:84956818125

SN - 9783319225098

SN - 9783319225081

SP - 3

EP - 22

BT - Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology

PB - Springer International Publishing

ER -